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Effect of blood cooling on cuprophan-induced anaphylatoxin genera-
tion. We investigated whether cooling of the extracorporeal blood
during hemodialysis could prevent anaphylatoxin generation and leu-
kopenia caused by blood-cuprophan contact. After preliminary in vitro
studies confirming the temperature dependence of CSa generation, we
carried out hypothcrmic dialysis on nine patients by manipulating blood
and dialysate temperature in such a way that blood temperature within
the dialyzer averaged 25°C. In comparison with the control procedure
(blood temperature within the dialyzer 35°C) hypothermic dialysis
reduced peak C5a generation from 41.7 17 ng/ml to 9.7 3.4 nglml (P
<0.01), and white btood cell fall from 72 15 to 25 20% (P C 0.01).
Arterial P02 decreased less in hypothermic dialysis (—19 9% of
pre-HD value) than in the control procedure (—30 11%) (P < 0.05).
We conclude that blood cooling attenuates cuprophan-induced anaphy-
latoxin generation and leukopenia.
Exposure of blood to certain foreign surfaces as occurs
during hemodialysis (HD), cardiopulmonary bypass and nylon
fiber leukoapheresis, causes complement (C) activation via the
alternative pathway mechanism [1—3]. The intensity of C acti-
vation varies with the material employed for extracorporeal
circulation, new cuprophan membrane causing a much more
marked activation than reused cuprophan, polyacrylonitrile or
polymethylmethacrylate membranes [4, 5]. A manifestation of
C activation is transient but profound leukopenia occurring
early during HD treatment, which is thought to result from
pulmonary sequestration of granulocytes aggregated by the
complement-derived fragment C5a [6—8].
In the course of studies aimed at assessing the effect of
varying dialysate temperatures (T) on cardiovascular stability
during HD treatment, we noted that in the 38° to 20°C range the
lower the dialysate T was set, the milder the leukopenia [9].
This observation led us to investigate the influence of T on C
activation by cuprophan membrane. To this end we evaluated
the intensity of C activation from the amount of C5a antigen
generated both in vitro and in vivo. The results of the investi-
gation form the object of the present report.
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Methods
In vitro study
Four heparinized plasma samples from each of eight subjects
(4 staff members and 4 patients) were incubated with cupro-
phan membrane (1 ml/plasma per 20 cm2 membrane) in revolv-
ing plastic tubes, immersed in thermostatic water baths set at
temperatures of 16°, 20°, 30°, and 37°C, respectively. After 60
minutes EDTA was added to plasma and its C5a concentration
determined.
In vivo study
Nine patients (5 males, 4 females), who had been undergoing
thrice weekly hemodialysis (HD) treatment for one to seven
years (average 2.7), took part in this study. They were free of
any related disease, their ages ranged from 25 to 71 years
(average 52.5), and they were not taking any medication other
than phosphate binders and vitamins. Diagnosis of renal disease
was interstitial nephropathy (3), unknown etiology (4), diabetic
nephropathy (1), and renal vascular disease (1).
Each patient randomly underwent one isothermic and one
hypothermic HD treatment. For the purpose of this study, HD
treatments were carried out with a special extracorporeal line
containing a serpentine tube 200 cm long in both the arterial
(dialyzer afferent) and venous (dialyzer efferent) segments.
During hypothermic HD, dialysate fluid flowed unwarmed
through the dialyzer while the arterial serpentine tube was kept
immersed in a bath of running tap water. Before re-entering the
patient, blood was rewarmed by immersing the venous serpen-
tine tube in a thermostatic bath set at 39° to 41°C. During
isothermic HD, both the arterial and the venous serpentine
tubes were kept in a water bath at 37°C while dialysate fluid
flowed through the dialyzer at a T of 37°C. All HD treatments
were carried out with new Cuprophan, hollow fiber dialyzers of
1.2 m2 diameter (GF 120H Gambro, Lund, Sweden), at a blood
flow of 250 mI/mm and a dialysate flow of 500 ml/min. Dialysate
composition was: Na 138, K 1.5, Cat 3.8, Mgil 1.0,
acetate 36.9 mEq/liter.
Temperature was monitored by means of thermocouple nee-
dles (Ellab) placed in the blood and dialysate circuits. Blood T
within the dialyzer was calculated as the average of pre- and
post-dialyzer blood T. Blood gases, leukocyte and differential
count were determined in duplicate on blood drawn from the
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arterial line at 0, 15, 30, 60, 120 and 240 minutes of HD. At the
same time intervals, blood for measurement of C5a antigen was
obtained from both the arterial (afferent) and venous (efferent)
line of the dialyzer. Blood was drawn in tubes containing
EDTA, immediately centrifuged, separated and stored at —80°C
until processing.
C5a antigen was determined by RIA (Upjohn Kalamazoo,
Michigan, USA); white blood cell and differential count was
determined by a manual method. Dialyzer urea and creatinine
clearance were determined by standard methods at the end of
the second hour of HD treatment. Blood gases were determined
by a Radiometer ABL2 gas analyzer.
Statistical analysis was performed by paired Wilcoxon test.
Correlated parameters were done by using linear and exponen-
tial regression analysis. Data are presented as mean standard
deviation.
Results
In vitro study
C5a generation after 60 minutes was, as expected, strictly T
dependent. The relationship between the T changes in Celsius
degrees (x) and in vitro C5a generation (y) is defined by the
equation y = 6.41 . 2.7l8°'°' (in terms of Kelvin degrees y =
7,5—13 . 2.7l80b09o) (r = 0.917; P < 0.001). According to this
equation, lowering the T from 35° to 25°C decreases C5a
generation by 60%. A further lowering to 15°C reduces its
generation by 90%.
In vivo study
Calculated blood T within the dialyzer averaged 24.9° 1.3°C
during hypothermic HD, 35.3° 1.0°C during isothermic HD.
Rewarming the venous line was not sufficient to bring blood T
to the same level as in isothermic dialysis. Probably as a result
of this greater heat loss from the extracorporeal circuit, rectal T
rose less during hypothermic HD, even though the difference
was not statistically significant.
Venous C5a concentration increased from 3.1 1.5 ng/ml to
a peak of 41.7 17 nglml during isothermic HD, and from 4.6
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Fig. 3. Relationship between C5a release and white blood cell nadir
changes.
2.6 ng/ml to 9.7 3.4 ng/ml during hypothermic HD (Fig. 1).
The difference in C5a variation between the two procedures
was highly significant (P < 0.01). The peak concentrations
occurred after 15 or 30 minutes in isothermic HD and in six out
of nine hypothermic HD patients, while in the remaining three
hypothermic treatments the peak was delayed for 60 minutes.
In arterial blood the C5a concentration increased slightly during
isothermic HD after 15 minutes, whereas it remained almost
unchanged through the hypothermic HD.
Concurrently with this effect on C5a generation, hypothermic
HD reduced the degree of white blood cell count maximal fall
from 72 15% to 25 20% (P < 0.01) (Fig. 2). In both
procedures the fall in white blood cells was caused mainly by
neutrophil depletion. The maximum fall in WBC (y) bore a
significant relationship with the concurrent rise in C5a concen-
tration (x) in venous blood (r = 0.71; y = —0.918 x +70.349;
P < 0.01) (Fig. 3). It always occurred at 15 minutes in isothermic
HD, while in hypothermic HD it was observed in three patients at
15 minutes, in four at 30 minutes, and in two at 60 minutes.
Pa02 dropped significantly less during hypothermic than
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during isothermic HD, the maximal drop occurring after 60
minutes to 81 9 and 71 11% of the predialysis values,
respectively (P c 0.05) (Fig. 4). PaCO2 changes, on the other
hand, were similar during both iso- and hypothermic HD.
In comparison with isothermic HD, hypothermic HD caused
a decrease in both urea and creatinine clearance from 182 21
to 151 16 mi/mm, and from 150 14 to 126 15 mi/mm,
respectively (P < 0.01).
Discussion
Like other polysaccharidic substances cuprophan membrane
is capable of activating the alternative pathway of complement
cascade [1, 2]. As originally shown by Pillemer et a! in the early
fifties [10], fully confirmed by our in vitro studies employing a
completely different assay system, activation of the alternative
pathway is temperature dependent. The dose-response curve
between T and anaphylatoxin generation conforms to an expo-
nential relationship, such as generation of C5a, is strongly
curtailed when the T of reaction is lowered below 30°C.
The results obtained in vivo with hypothermic dialysis were
substantially in line with the in vitro findings. With our home-
made system, the lowest obtainable T value of blood contacting
the dialyzer membrane was 25°C. On comparing the actual peak
concentrations of anaphylatoxins during the two dialytic pro-
cedures, we found that hypothermic dialysis caused a 77%
decrease in C5a peak values. The diminished C activation was
mirrored by a lower drop in white blood cell count, thus lending
support to the notion that C activation is the cause of granulo-
cytopenia [4, 5, 8].
Together with the milder leukopenia and the blunted C
activation, there occurred less PaO2 decrease during hypother-
mic than during isothermic dialysis. Arterial hypoxia occurring
during acetate dialysis is currently believed to result from C
activation [11] and/or reflex hypoventilation evoked by the loss
of CO2 through the dialyzing membrane [12, 13]. Blood cooling
might have decreased Pa02 drop by reducing the degree of both
C activation and CO2 loss through the dialyzer. To the extent
that arterial hypoxia may depend on increased 02 consumption,
as suggested by some authors [13], even the lesser increase in
core T occurring during hypothermic dialysis might have con-
tributed to the decreased Pa02 fall. However, since this study
was not designed to explore these mechanisms, we cannot draw
any conclusions about the cause of decreased hypoxia during
hypothermic HD.
Dialysis-borne C activation can be largely avoided if reused
Cuprophan or non-cellulosic membranes are employed [4, 5].
Even dialysis hypoxia, which can be deleterious in some
patients, can be largely prevented if bicarbonate instead of
acetate is used as buffer in the dialysis bath [13]. It appears
more practical to resort to these means than to cool the blood
within the dialyzer, not least because these means, unlike blood
cooling, do not entail any reduction in dialyzing efficiency.
Perhaps, the effect of cooling on C activation can be exploited
240 to greater advantage in other types of extracorporeal circulation
such as cardiopulmonary bypass [3]. In this case, as against in
that of dialysis, optional materials devoid of the property of
activating the C system are not presently available. Activation
of C cascade is suspected as a key factor in the pathogenesis of
clinical catastrophies occasionally occurring following an un-
eventful cardiopulmonary bypass. To shed some light on this
problem a means of preventing C activation, such as cooling of
extracorporeal blood to an appropriate degree, appears worthy
of being exploited.
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